Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.520
+0.030 (2.01%)
At close: Apr 2, 2026, 4:00 PM EDT
1.538
+0.018 (1.17%)
After-hours: Apr 2, 2026, 7:58 PM EDT
Neuronetics Revenue
In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth. Neuronetics had revenue of $41.78M in the quarter ending December 31, 2025, with 85.73% growth.
Revenue (ttm)
$149.16M
Revenue Growth
+99.17%
P/S Ratio
0.71
Revenue / Employee
$226,682
Employees
658
Market Cap
105.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.16M | 74.27M | 99.17% |
| Dec 31, 2024 | 74.89M | 3.54M | 4.96% |
| Dec 31, 2023 | 71.35M | 6.14M | 9.42% |
| Dec 31, 2022 | 65.21M | 9.89M | 17.89% |
| Dec 31, 2021 | 55.31M | 6.07M | 12.32% |
| Dec 31, 2020 | 49.24M | -13.41M | -21.41% |
| Dec 31, 2019 | 62.66M | 9.88M | 18.72% |
| Dec 31, 2018 | 52.78M | 12.34M | 30.53% |
| Dec 31, 2017 | 40.43M | 6.21M | 18.13% |
| Dec 31, 2016 | 34.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 212.69M |
| Xtant Medical Holdings | 133.08M |
| AVITA Medical | 71.61M |
| Rapid Micro Biosystems | 33.59M |
| MaxCyte | 33.03M |
| Baird Medical Investment Holdings | 31.86M |
| QT Imaging Holdings | 18.93M |
| Hyperfine | 13.56M |
STIM News
- 17 days ago - Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 17 days ago - Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer - GlobeNewsWire
- 7 weeks ago - Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 4 months ago - Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga
- 5 months ago - TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression - GlobeNewsWire
- 5 months ago - Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript - Seeking Alpha